Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Titel:
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
Auteur:
Grinsztejn, Beatriz De Castro, Nathalie Arnold, Vincent Veloso, Valdiléa G Morgado, Mariza Pilotto, José Henrique Brites, Carlos Madruga, José Valdez Barcellos, Nêmora Tregnago Santos, Breno Riegel Vorsatz, Carla Fagard, Catherine Santini-Oliveira, Marilia Patey, Olivier Delaugerre, Constance Chêne, Geneviève Molina, Jean-Michel